NCT01560858 Treatment Patterns Among Patients With Prostate Cancer Prior to Diagnosis of a Castration-resistant State Status COMPLETED Phase N/A
NCT01471405 One Year Follow-up of Study 2-79-52030-207 (PRIMARYS) in Acromegalic Patients With Macroadenoma Status COMPLETED Phase N/A
NCT01444794 Adult Subjects Suffering From Lower Limb Spasticity Following Stroke Status COMPLETED Phase N/A
NCT01438801 Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF) Status WITHDRAWN Phase PHASE4
NCT01383863 A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer Status COMPLETED Phase N/A
NCT01374087 Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer Status TERMINATED Phase PHASE2
NCT01372007 Influence of Somatuline Autogel 120mg on Post-operative Drainage After Total Mesorectum Excision for Rectumcarcinoma Status COMPLETED Phase PHASE3
NCT01357980 Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT01354405 Somatostatin Analogues as a Volume Reducing Treatment of Polycystic Livers (RESOLVE) Status COMPLETED Phase N/A
NCT01351051 A Study of the Potential Risk Factors Linked to the Development of Severe Forms of Endometriosis Status COMPLETED Phase N/A
NCT01333397 Safety and Efficacy Study of Dysport RU and Glabellar Lines Status COMPLETED Phase PHASE2
NCT01333384 Study in Polish Acromegalic Patients Treated With Somatuline Autogel Status COMPLETED Phase N/A
NCT01315795 Lanreotide Autogel in the Treatment of Symptomatic Polycystic Liver Disease Status COMPLETED Phase PHASE2/PHASE3
NCT01314365 DYSPORT™ Clinical & Health Economics Outcomes Registry in Cervical Dystonia Status COMPLETED Phase N/A
NCT01313273 Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients Status TERMINATED Phase PHASE3
NCT01261611 Study Comparing Short Term Efficacy of Dysport and Dysport NG to Placebo, and to Assess Efficacy and Safety of Dysport NG of Subjects With Cervical Dystonia Status COMPLETED Phase PHASE3
NCT01257425 Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg Status COMPLETED Phase PHASE2